These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25242701)

  • 1. Botulinum toxin A for children with salivary control problems.
    Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
    Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].
    Hernández-Palestina MS; Cisneros-Lesser JC; Arellano-Saldaña ME; Plascencia-Nieto SE
    Cir Cir; 2016; 84(6):459-468. PubMed ID: 27221328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
    Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
    Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.
    Toulemonde P; Maltezeanu A; Broucqsault H; Fayoux P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):77-81. PubMed ID: 34217684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
    Shariat-Madar B; Chun RH; Sulman CG; Conley SF
    Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R; Diamond M; Elovic E; Millis SR
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
    Sidebottom AJ; May JE; Madahar AK
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL; Tilton A
    Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
    Møller E; Pedersen SA; Vinicoff PG; Bardow A; Lykkeaa J; Svendsen P; Bakke M
    Toxins (Basel); 2015 Jun; 7(7):2481-93. PubMed ID: 26134257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
    Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
    Chan KH; Liang C; Wilson P; Higgins D; Allen GC
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.